Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John A. Schoenhard
Plasminogen Activator Inhibitor-1 Deficiency Prevents Hypertension and Vascular Fibrosis in Response to Long-Term Nitric Oxide Synthase Inhibition
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Inhibition of Angiogenesisin Vivoby Plasminogen Activator Inhibitor-1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition.
Journal of Clinical Investigation
Medicine
Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency
Haemophilia
Medicine
Genetics
Hematology
Nitric Oxide (No) Synthase Inhibition Prevents Surfactant-Induced Cerebral Vasodilatation in Newborn Piglets With Surfactant Deficiency. 2123
Pediatric Research
Child Health
Pediatrics
Perinatology
Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease
Cardiology Research
Cardiovascular Medicine
Cardiology
Hybrid Inhibitor of Peripheral Cannabinoid-1 Receptors and Inducible Nitric Oxide Synthase Mitigates Liver Fibrosis
JCI insight
Medicine
Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced in Vitro Cerebral Angiogenesis
PLoS ONE
Multidisciplinary
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
